Cart
sales@molnova.com
Eldacimibe
CAS No. 141993-70-6
Eldacimibe( —— )
Catalog No. M34583 CAS No. 141993-70-6
Eldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 333 | In Stock |
|
| 10MG | 504 | In Stock |
|
| 25MG | 816 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2967 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEldacimibe
-
NoteResearch use only, not for human use.
-
Brief DescriptionEldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
-
DescriptionEldacimibe (WAY-ACA-147) is an ACAT2 inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, study of atherosclerosis and hypercholesterolemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAcyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number141993-70-6
-
Formula Weight634.89
-
Molecular FormulaC39H58N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N(CC1=CC=C(CC(C)(C)C)C=C1)CCCCCC)(NC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)=C3C(=O)OC(C)(C)OC3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
yibeinoside A
Yibeinoside A is an alkaloid from Fritillaria pallidiflora.
-
Nemvaleukin alfa
Nemvaleukin alfa (ALKS 4230) is an interleukin 2 fusion protein, a selective agonist of the medium-affinity IL-2 receptor, produced by fusion of the IL-2Ralpha subunit of the circularly arranged interleukin-2 (IL-2) and IL-2 receptor (IL-2R) complexes, which drives antitumor Immunity and inhibits tumor growth in small cell lung cancer.
-
Oxynitidine
Oxynitidine is an HBV inhibitor (ID50=30.8 μg/mL), which can effectively inhibit the DNA replication activity of HBV. Oxynitidine can be used in the study of viral infections.
